Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

TerminatedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

March 4, 2022

Study Completion Date

March 4, 2022

Conditions
COVID-19
Trial Locations (32)

13210

SUNY Upstate Medical University, Syracuse

37208

Meharry Medical College/Meharry Medical Center, Nashville

68198

University of Nebraska Medical Center, Omaha

78229

Clinical Trials of Texas, LLC, San Antonio

78520

Pan American Clinical Research LLC, Brownsville

02215

Beth Israel Deaconess Medical Center, Boston

Unknown

Clinisalud, Envigado

Bluecare Salud SAS, Bogotá

Servimed SAS, Bucaramanga

University Hospital Center of Guadeloupe, Les Abymes

Andhra Medical College, Visakhapatnam

Unity Hospital, Surat

GMERS Medical College & Hospital, Vadodara

Government Medical College & Hospital, Aurangabad

Govt. Medical College, Nagpur

Grant Medical Foundation Ruby Hall Clinic, Pune

Peerless Hospitex Hospital, Kolkata

Icaro Investigaciones en Medicina SA de CV, Chihuahua City

Worthwhile Clinical Trials, Benoni

REIMED Wilhase Practice, Boksburg

Clinresco Centres, Kempton Park

Larisha Pillay-Ramaya, Pretoria

Muhammed Ameen Fulat, Pretoria

Johan Geldenhuys, Vereeniging

DR P J Sebastian Clinical Research Centre, Durban

Synapta Clinical Research Centre, Durban

Clinical Research Institute of South Africa (CRISA), KwaDukuza

Aurum Klerksdorp CRS, Klerksdorp

The Aurum Institute, Rustenburg Clinical Research Site, Rustenburg

Langeberg Clinical Trials, Cape Town

Task Applied Science, Cape Town

00716

CAIMED Center at the Ponce School of Medicine, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Pharm-Olam, LLC

INDUSTRY